Decoding AI: Unveiling the Future of Machine Intelligence
Molecular Design
Medical companies leverage cutting-edge technology that learns from vast amounts of data to reimagine drug discovery. This shift from laborious craftsmanship to precise automation is propelled by artificial intelligence, evolving and becoming more intelligent.
Jacob Berlin, CEO of Terray Therapeutics, emphasizes the power of AI, stating that with the right data, AI can excel.… Read the rest
Merantix, a Berlin-based venture studio, is placing a significant bet on the transformational power of generative artificial intelligence (AI). Nicole Büttner of Merantix, speaking on the podcast “Die Stunde Null,” compared the potential impact of generative AI to landmark innovations such as the internet and electricity.… Read the rest
Revolutionizing Agricultural Chemicals through AI
In England, researchers are harnessing the power of Artificial Intelligence to explore the healing properties of plants. Moving away from traditional synthetic herbicides and pesticides, AI is now being used to conceive what is metaphorically described as the ideal molecule for plant protection.… Read the rest
DeepMind, the artificial intelligence powerhouse, has revealed an advanced version of its celebrated AI model at the Google I/O conference. This model, known as AlphaFold 3, holds the potential to revolutionize various industries by predicting not just the structure of proteins, but effectively simulating the architecture of all molecular participants in the dance of life.… Read the rest
Korean researchers have paved the way for groundbreaking pharmaceutical discoveries through an innovative use of generative artificial intelligence (AI). The team led by Professor Woo Youn Kim from KAIST’s Department of Chemistry has developed a novel AI that can design drugs suitable for target proteins purely based on the interaction patterns between proteins and molecules, without relying on active data.… Read the rest
Local research teams have presented a promising future for the use of generative AI in drug design. Prof. Woo-Yeon Kim’s team from KAIST’s Department of Chemistry has developed a ‘drug design generative AI’ that can propose suitable drugs for target proteins, taking into account interactions between proteins and molecules, even without existing activity data.… Read the rest
Artificial Intelligence (AI) has made significant strides in various fields, and education is no exception. In early 2023, Professor Alice Oh and her team at the Korea Advanced Institute of Science and Technology (KAIST) recognized the need to harness the potential of AI, specifically OpenAI’s ChatGPT, for their students.… Read the rest
The search for effective and affordable materials for carbon capture is an ongoing challenge in the fight against climate change. Metal-organic frameworks (MOFs) have shown promise as a candidate for selective carbon dioxide absorption, but the traditional methods of designing and testing these materials are time-consuming and costly.… Read the rest